Skip to main content
Stem Cell Research & Therapy logoLink to Stem Cell Research & Therapy
. 2022 Aug 5;13:402. doi: 10.1186/s13287-022-03108-3

Retraction Note: TGFβ3 recruits endogenous mesenchymal stem cells to initiate bone regeneration

Moyuan Deng 1, Tieniu Mei 1, Tianyong Hou 1, Keyu Luo 1, Fei Luo 1, Aijun Yang 1, Bo Yu 1, Hao Pang 3,, Shiwu Dong 1,2,, Jianzhong Xu 1,
PMCID: PMC9354353  PMID: 35932081

Retraction Note to: Stem Cell Research & Therapy (2017) 8:258 https://doi.org/10.1186/s13287-017-0693-0

The Editors-in-Chief have retracted this article. After publication, concerns were raised regarding potential image duplication in the figures.

Specifically:

  • In Fig. 1b, the 0 ng + SB and 25 ng + SB group images appear to originate from the same sample (rotated 90 degrees);

  • In Fig. 1c, TβRII lane 3 and GAPDH lanes 2 and 3 appear highly similar to Fig. 3d hUASMC p-Smad3 lane 1 and β-actin (both lanes), respectively;

  • In Fig. 4d, the images for the hUVEC and Scrambled hUVEC groups appear to contain overlap.

The authors have stated that these issues occurred due to errors in data storage. Additionally, they have been unable to provide the raw images of the western blots presented in Fig. 1c. The Editor-in-Chief therefore no longer has confidence in the presented data.

Jianzhong Xu has stated on behalf of all authors that none of the authors agree to this retraction.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Hao Pang, Email: 340062474@qq.com.

Shiwu Dong, Email: dongshiwu@163.com.

Jianzhong Xu, Email: jianzhong_xu@126.com.


Articles from Stem Cell Research & Therapy are provided here courtesy of BMC

RESOURCES